About
Cutting-Edge Solution
Clemson Continues to Lead
The REDDI Lab is home to Clemson University’s first high complexity Clinical Laboratory Improvement Amendments (CLIA) certified facility (ID: 42D2193465).
Established in Fall 2020, the Clemson University Research and Education in Disease Diagnosis and Intervention (REDDI) Lab was founded by Dr. Delphine Dean in response to the COVID-19 global pandemic.
The University received $6.9 million through the State to assist in developing and expanding the CLIA Lab. The expansion was a multidisciplinary, university-wide effort to create a lab that was a cutting-edge solution to help fight COVID-19.
The REDDI lab is ready to look past the COVID-19 pandemic and tackle new and existing challenges at the local and global levels.
Mission and Goals
The mission of the REDDI Lab is to operate as a high complexity public health laboratory for upstate South Carolina and design and produce deployable diagnostics, therapeutics, and screening systems for remote communities.
Supporting COVID Research
